Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 128 participants.
Also called NCT06359782
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 128 participants
- Registry
-
NCT06359782
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT06359782. Randomized; quadruple masking; primary purpose treatment. Start 2024-11-04 (actual); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
- Acronym
- CIAO@SAH
- Condition
- Subarachnoid Hemorrhage, Aneurysmal
- Intervention (Drug)
- C1 Esterase Inhibitor Injection [Cinryze]
- Intervention (Drug)
- Placebo
- Lead sponsor
- Haaglanden Medical Centre
- Collaborator
- Leiden University Medical Center
- Collaborator
- Takeda
Record details
- Record id
cardio:ct-nct06359782- Content hash
c5f66b7464caae85256d520c83ad1f32f8be2dab799cf685d44335d9d31ec23f